Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
1.180
-0.070 (-5.60%)
At close: Dec 5, 2025, 4:00 PM EST
1.240
+0.060 (5.08%)
After-hours: Dec 5, 2025, 6:55 PM EST
Citius Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '25 Jun 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Net Income | -40.26 | -39.14 | -32.54 | -33.64 | -23.05 | -17.55 | |
| Depreciation & Amortization | 0.21 | 0.21 | 0.19 | 0.18 | 0.16 | 0.15 | |
| Stock-Based Compensation | 10.59 | 12.12 | 6.72 | 4.28 | 1.52 | 1.33 | |
| Other Operating Activities | -0.87 | 0.29 | 0.58 | 0.58 | -0.17 | - | |
| Change in Inventory | -11.07 | -2.13 | - | - | - | - | |
| Change in Accounts Payable | 8.43 | 2 | 1.76 | -0.11 | -0.58 | -0.86 | |
| Change in Other Net Operating Assets | 12.4 | -1.55 | -5.77 | 0.35 | -2.14 | -0.01 | |
| Operating Cash Flow | -20.58 | -28.2 | -29.06 | -28.36 | -24.25 | -16.93 | |
| Capital Expenditures | - | - | - | - | -0.01 | -0 | |
| Sale (Purchase) of Intangibles | -5 | -5 | - | - | -40 | - | |
| Investing Cash Flow | -5 | -5 | - | - | -40.01 | -0 | |
| Long-Term Debt Issued | - | - | - | - | - | 0.16 | |
| Total Debt Issued | 1.3 | - | - | - | - | 0.16 | |
| Short-Term Debt Repaid | - | - | - | - | -0.17 | - | |
| Total Debt Repaid | - | - | - | - | -0.17 | - | |
| Net Debt Issued (Repaid) | 1.3 | - | - | - | -0.17 | 0.16 | |
| Issuance of Common Stock | 16.59 | 13.8 | 15.03 | - | 127.71 | 24.27 | |
| Other Financing Activities | -4.13 | -3.83 | -1.2 | - | -7.07 | -1.54 | |
| Financing Cash Flow | 13.76 | 9.97 | 13.83 | - | 120.47 | 22.9 | |
| Net Cash Flow | -11.82 | -23.23 | -15.23 | -28.36 | 56.21 | 5.97 | |
| Free Cash Flow | -20.58 | -28.2 | -29.06 | -28.36 | -24.26 | -16.93 | |
| Free Cash Flow Per Share | -2.40 | -4.19 | -4.80 | -4.85 | -5.58 | -10.81 | |
| Cash Interest Paid | - | - | - | - | 0.04 | - | |
| Levered Free Cash Flow | 18.36 | 8.02 | -19.85 | -15.94 | -55.61 | -10.34 | |
| Unlevered Free Cash Flow | 18.47 | 8.02 | -19.85 | -15.94 | -55.61 | -10.33 | |
| Change in Working Capital | 9.76 | -1.69 | -4.01 | 0.24 | -2.72 | -0.87 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.